Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- PMID: 23390181
- PMCID: PMC3719424
- DOI: 10.1212/WNL.0b013e31828726f5
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Abstract
Objectives: To provide updated estimates of Alzheimer disease (AD) dementia prevalence in the United States from 2010 through 2050.
Methods: Probabilities of AD dementia incidence were calculated from a longitudinal, population-based study including substantial numbers of both black and white participants. Incidence probabilities for single year of age, race, and level of education were calculated using weighted logistic regression and AD dementia diagnosis from 2,577 detailed clinical evaluations of 1,913 people obtained from stratified random samples of previously disease-free individuals in a population of 10,800. These were combined with US mortality, education, and new US Census Bureau estimates of current and future population to estimate current and future numbers of people with AD dementia in the United States.
Results: We estimated that in 2010, there were 4.7 million individuals aged 65 years or older with AD dementia (95% confidence interval [CI] = 4.0-5.5). Of these, 0.7 million (95% CI = 0.4-0.9) were between 65 and 74 years, 2.3 million were between 75 and 84 years (95% CI = 1.7-2.9), and 1.8 million were 85 years or older (95% CI = 1.4-2.2). The total number of people with AD dementia in 2050 is projected to be 13.8 million, with 7.0 million aged 85 years or older.
Conclusion: The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
Figures
Similar articles
-
Deaths in the United States among persons with Alzheimer's disease (2010-2050).Alzheimers Dement. 2014 Mar;10(2):e40-6. doi: 10.1016/j.jalz.2014.01.004. Alzheimers Dement. 2014. PMID: 24698031 Free PMC article.
-
Alzheimer disease in the US population: prevalence estimates using the 2000 census.Arch Neurol. 2003 Aug;60(8):1119-22. doi: 10.1001/archneur.60.8.1119. Arch Neurol. 2003. PMID: 12925369
-
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):169-73. doi: 10.1097/00002093-200110000-00002. Alzheimer Dis Assoc Disord. 2001. PMID: 11723367
-
Alzheimer's disease: preventing and recognizing a misdiagnosis.Nurse Pract. 1997 Oct;22(10):58-9, 63-8, 70, passim. Nurse Pract. 1997. PMID: 9355117 Review.
-
An overview of the etiology, diagnosis, and treatment of Alzheimer disease.Phys Ther. 1998 Dec;78(12):1325-31. doi: 10.1093/ptj/78.12.1325. Phys Ther. 1998. PMID: 9859951 Review.
Cited by
-
The impact of cognitive impairment on survival and medication adherence among older women with breast cancer.Breast Cancer. 2021 Mar;28(2):277-288. doi: 10.1007/s12282-020-01155-3. Epub 2020 Sep 9. Breast Cancer. 2021. PMID: 32909167
-
Worries about getting Alzheimer's: who's concerned?Am J Alzheimers Dis Other Demen. 2015 Sep;30(6):591-8. doi: 10.1177/1533317514568889. Epub 2015 Feb 4. Am J Alzheimers Dis Other Demen. 2015. PMID: 25657292 Free PMC article.
-
Are the Nuclear Neuro-Imaging Biomarkers Reliable?Nucl Med Mol Imaging. 2024 Jun;58(4):158-159. doi: 10.1007/s13139-024-00865-2. Epub 2024 May 25. Nucl Med Mol Imaging. 2024. PMID: 38932761 No abstract available.
-
Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia.J Am Geriatr Soc. 2016 Jun;64(6):1223-32. doi: 10.1111/jgs.14164. Epub 2016 Jun 2. J Am Geriatr Soc. 2016. PMID: 27253366 Free PMC article.
-
Vestibular Impairment in Dementia.Otol Neurotol. 2016 Sep;37(8):1137-42. doi: 10.1097/MAO.0000000000001157. Otol Neurotol. 2016. PMID: 27466890 Free PMC article.
References
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119–1122 - PubMed
-
- Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 2003;60:185–189 - PubMed
-
- Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 2003;5:349–355 - PubMed
-
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical